← Back to headlines
Aprea Therapeutics and PolyPid Announce Q2 Earnings
Aprea Therapeutics reported a GAAP EPS of -$0.07, surpassing estimates by $0.16, while PolyPid announced a GAAP EPS of -$0.35, beating expectations by $0.03.
12 Aug, 12:32 — 12 Aug, 12:32
Sources
Showing 1 of 1 sources
Related Stories
IMF Chief Warns Global Economy Faces Energy Shocks and Fiscal Pressures
16m ago
Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance
32m ago
TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe
36m ago
Montenegro Official Rejects Alleged Political Pressure Attempts
38m ago